{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:13:45Z","timestamp":1790723625018,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014255","name":"Fonds de dotation CSL Behring pour la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.thromres.2014.02.015","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T19:00:56Z","timestamp":1393009256000},"page":"967-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?"],"prefix":"10.1016","volume":"133","author":[{"given":"Thierry","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Auerswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Jim\u00e9nez-Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Ljung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Morfini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-8700","authenticated-orcid":false,"given":"Eduardo","family":"Remor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Santagostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva","family":"Zupan\u010di\u0107 \u0160alek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.02.015_bb0005","first-page":"3","article-title":"Prophylaxis: musculoskeletal evaluation","volume":"30","author":"Gilbert","year":"1993","journal-title":"Semin Hematol"},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2014.02.015_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2516.2004.00978.x","article-title":"Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions","volume":"10","author":"Manco-Johnson","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0015","series-title":"Orthopedic Surgery in Patients With Hemophilia","first-page":"15","article-title":"Conservative or surgical treatment? Motion analysis can help decide","author":"Seuser","year":"2008"},{"key":"10.1016\/j.thromres.2014.02.015_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2106\/00004623-197759030-00001","article-title":"Hemophilic arthropathy. Current concepts of pathogenesis and management","volume":"59","author":"Arnold","year":"1977","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.thromres.2014.02.015_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00003086-198006000-00018","article-title":"A radiologic classification of hemophilic arthropathy","volume":"149","author":"Pettersson","year":"1980","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.thromres.2014.02.015_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2516.2011.02682.x","article-title":"Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis","volume":"18","author":"Olivieri","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0035","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1365-2516.2012.02883.x","article-title":"An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group","volume":"18","author":"Lundin","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2014.02.015_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2516.2006.01265.x","article-title":"Recent developments in clinimetric instruments","volume":"12","author":"Beeton","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2516.2010.02399.x","article-title":"Range of motion measurements: reference values and a database for comparison studies","volume":"17","author":"Soucie","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2516.2010.02400.x","article-title":"The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A","volume":"17","author":"Soucie","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2516.2012.02791.x","article-title":"Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va)","volume":"18","author":"Poon","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2516.2006.01187.x","article-title":"Computerized pedobarography in the characterization of ankle-foot instabilities of haemophilic patients","volume":"12","author":"Jorge Filho","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl. 5","key":"10.1016\/j.thromres.2014.02.015_bb0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2516.2010.02312.x","article-title":"Comprehensive elements of a physiotherapy exercise programme in haemophilia-a global perspective","volume":"16","author":"Blamey","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2516.2011.02672.x","article-title":"Ultrasonography of haemophilic arthropathy","volume":"18","author":"Muca-Perja","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2516.2010.02380.x","article-title":"Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score","volume":"17","author":"Melchiorre","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0085","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2010-05-284653","article-title":"Neoangiogenesis contributes to the development of hemophilic synovitis","volume":"117","author":"Acharya","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.02.015_bb0090","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3899\/jrheum.120370","article-title":"RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology","volume":"39","author":"Melchiorre","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.thromres.2014.02.015_bb0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.24184","article-title":"The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy","volume":"60","author":"Jansen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.thromres.2014.02.015_bb0100","first-page":"e1","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2012","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2014.02.015_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2516.2007.01507.x","article-title":"Orthopaedic issues in sports for persons with haemophilia","volume":"13","author":"Seuser","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0110","first-page":"CD003429","article-title":"Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B","author":"Iorio","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2014.02.015_bb0115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2011.04214.x","article-title":"A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)","volume":"9","author":"Gringeri","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.02.015_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2516.9.s1.1.x","article-title":"When to start and when to stop primary prophylaxis in patients with severe haemophilia","volume":"9","author":"Astermark","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0125","author":"National Hemophilia Foundation"},{"key":"10.1016\/j.thromres.2014.02.015_bb0130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2010.08139.x","article-title":"A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A","volume":"149","author":"Richards","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.02.015_bb0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2516.2001.00560.x","article-title":"Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome","volume":"7","author":"Fischer","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2005.05546.x","article-title":"Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands","volume":"130","author":"van Dijk","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.02.015_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2516.2007.01478.x","article-title":"Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data","volume":"13","author":"Richards","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0150","first-page":"165","article-title":"Prophylaxis in haemophilia should be life-long","volume":"10","author":"Makris","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.thromres.2014.02.015_bb0155","first-page":"515","article-title":"Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease","volume":"244","author":"Miners","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.thromres.2014.02.015_bb0160","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2516.2008.01791.x","article-title":"Effects of secondary prophylaxis started in adolescent and adult haemophiliacs","volume":"14","author":"Tagliaferri","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0165","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1538-7836.2007.02663.x","article-title":"Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors","volume":"5","author":"Konkle","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.02.015_bb0170","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1056\/NEJMoa1104435","article-title":"Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors","volume":"365","author":"Leissinger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2014.02.015_bb0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2516.2006.01204.x","article-title":"Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors","volume":"12","author":"Scalone","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2516.2010.02265.x","article-title":"The need for speed in the management of haemophilia patients with inhibitors","volume":"17","author":"Salek","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0185","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2516.2009.02007.x","article-title":"Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic","volume":"15","author":"Salaj","year":"2009","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2014.02.015_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2011.02615.x","article-title":"Joint protection in haemophilia","volume":"17","author":"Rodriguez-Merchan","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0195","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2516.2005.01087.x","article-title":"Rofecoxib as adjunctive therapy for haemophilic arthropathy","volume":"11","author":"Rattray","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0200","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2516.2006.01311.x","article-title":"Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia","volume":"12","author":"Rattray","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0205","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1111\/j.1365-2516.2010.02379.x","article-title":"Radioactive synovectomy with Yttrium90 citrate in haemophilic synovitis: Brazilian experience","volume":"17","author":"Thomas","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0210","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1538-7836.2011.04246.x","article-title":"Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters","volume":"9","author":"Corte-Rodriguez","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.02.015_bb0215","first-page":"e990","article-title":"What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with haemophilia?","volume":"17","author":"Corte-Rodriguez","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2516.2008.01952.x","article-title":"Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors","volume":"15","author":"Giangrande","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0225","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/hae.12028","article-title":"Consensus recommendations for the use of FEIBA\u00ae in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery","volume":"19","author":"Rangarajan","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2014.02.015_bb0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2516.2010.02223.x","article-title":"Rodriguez de la Rua A. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience","volume":"16","author":"Rodriguez-Merchan","year":"2010","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:37:07Z","timestamp":1758735427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0049384814000942"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.02.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}